1 year return (CAGR)
-75.08%
Heron Therapeuti Exchange (NASDAQ, USD)
HRTX
0.31
-0.00 (-0.41%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-37.56%
5 year return (CAGR)
-51.37%
10 year return (CAGR)
-33.18%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
59.61M
Price/Sales
0.39
Ent value
284.25M
Price/Book
8.63
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-45.44%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.31 |
| Daily high | 0.32 |
| Daily low | 0.31 |
| Daily Volume | 1.50M |
| All-time high | 1270.00 |
| 1y analyst estimate | 7.00 |
| Beta | 1.67 |
| EPS (TTM) | -0.18 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 4 Mar 2026 |
Downside potential
Loading...
Downside potential data
| HRTX | S&P500 | |
| Current price drop from All-time high | -99.98% | -2.63% |
| Highest price drop | -99.98% | -56.47% |
| Date of highest drop | 18 Aug 2026 | 9 Mar 2009 |
| Avg drop from high | -83.54% | -10.68% |
| Avg time to new high | 330 days | 12 days |
| Max time to new high | 8728 days | 1805 days |
News
